Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optical Monitoring of Neoadjuvant Chemotherapy and Prediction of Pathological Complete Response in Breast Cancer Patients

NCT04767659 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT04767659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04767659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optical Monitoring of Neoadjuvant Chemotherapy and Prediction of Pathological Complete Response in Breast Cancer Patients
Lead sponsor
IRCCS San Raffaele
Phase
Not applicable
Overall status
Recruiting
Start date
January 27, 2020
Completion date
August 30, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer female, chemotherapy effect